The Final Frontier Is Becoming Big Business. Here Are 3 Space Stocks to Buy Now.

The article argues SpaceX’s upcoming IPO could value the company at $1.75 trillion, implying roughly 94x trailing sales on $18.7 billion of last-year revenue, while noting investors cannot buy SpaceX alone because X and xAI have been merged into the deal. It highlights Rocket Lab, Planet Labs, and Voyager Technologies as purer-play alternatives, citing Rocket Lab’s under-$50 million Neutron launch price, Planet’s 24% revenue growth and nearly $58 million of free cash flow, and Voyager’s sub-16x sales multiple with a $2.6 billion market cap. Overall tone is cautious and comparative rather than event-driven.

Analysis

The market is not really being offered a clean SpaceX comparison set; it is being offered three different risk buckets. The important second-order effect is that a SpaceX IPO at an extreme revenue multiple will likely reset what investors are willing to pay for adjacent space equities, but only for a short window: high-profile “halo” rerating tends to compress quickly once secondary supply and lock-up concerns dominate attention. That makes the cleaner trade less about chasing the headline and more about owning the names with either defensible cash generation or clearly differentiated revenue pools.

Planet Labs looks best positioned if investors start separating “space” from “rocket,” because its valuation is still anchored to a public-market discount for a business that is now showing operating discipline. The hidden catalyst is budget quality: military and sovereign contracts are stickier than commercial imagery demand, and that changes the multiple regime from venture-style narrative to infrastructure-like durability. If that shift persists for 2-3 quarters, PL can rerate without needing hypergrowth, which is a better setup than the market usually gives it credit for.

Voyager is the most asymmetrically interesting because it sits in a capital-light consortium model rather than competing head-on in launch economics. The market may be underpricing optionality around space-station replacement because the end customer is effectively a government-backed demand pool with long procurement cycles; if Voyager remains one of the few credible integrators, momentum can compound through contract announcements rather than revenue inflection. The risk is binary: consortium churn, financing gaps, or policy slippage could erase the story quickly, so this is a longer-dated catalyst trade, not a near-term fundamentals trade.

Contrarian view: the biggest mistake is assuming the SpaceX IPO automatically lifts all space equities. A premium private-market valuation can just as easily expose public peers as cheap for a reason—execution risk, dilution, and lower-quality growth. In that setup, the better relative trade is to own the names with visible cash conversion and avoid those dependent on market enthusiasm for a multi-year buildout.

Key Decisions for Investors

• Long PL on a 3-6 month horizon; use any SpaceX IPO volatility to add on weakness. Risk/reward favors a rerate toward a higher-quality recurring revenue multiple if free cash flow remains positive.
• Initiate a small starter long VOYG for 6-18 months with a hard stop below the next contract-driven support level. This is a convex catalyst trade; upside is meaningful if Starlab momentum converts to procurement wins, but downside is high on any consortium or funding setback.
• Pair trade: long PL / short a higher-beta unprofitable space proxy if available in portfolio. The thesis is that investors will eventually pay for cash generation and sovereign demand over pure narrative exposure.
• Avoid chasing SpaceX-linked sympathy buying in the first 1-2 weeks post-IPO; wait for lock-up/secondary supply pressure before making relative value decisions across the space basket.
• If forced to express the theme tactically, use call spreads rather than outright longs in the weakest balance-sheet names; the sector is likely to trade on headline volatility before fundamentals catch up.